NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 08/24/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,552.75 mln
Float34.29 mln
Earnings Date11/18/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.19
Caution advised
1-Year Forecast
72.38
Limited downside
Relative Strength
76
/ 100
Strongly outperforming
Debt / Equity
0.04
Debt-free
ROE
-16.08
Negative
Business Description
GRAIL Inc. is a U.S.-based healthcare company focused on detecting multiple types of cancer at early stages through blood-based testing. Its flagship product, Galleri, screens for cancer in people over 50 who show no symptoms, while a separate test helps doctors reach faster conclusions for patients already suspected of having cancer. Founded in 2015 and based in Menlo Park, California, GRAIL also supports clinical research and offers tools that help track how cancer responds to treatment over time.
